 In December 2019 has been recognized a novel beta-coronavirus named 2019-nCoV and has rapidly spread across continents  71,333 cases (17 February 2020) have been reported among 29 countries in the four main continents with mortality nearby 2%  Fever with respiratory symptoms (e.g. cough, dyspnea) are the first signs of disease  High rate of radiological and clinical suspicious pneumonia were reported in reviewed cohorts of patients  Risk of bacterial superinfection and empirical antibiotic coverage have to be considered Abstract Objectives: Following the public health emergency declared by the World Health Organization and the recent outbreak by 2019-nCoV in China and through other 29 countries, we aimed to summarize J o u r n a l P r e -p r o o f 2 the clinical aspects of novel beta-coronavirus infection and its possible clinical presentations together with suggested therapeutic algorithms for patients who may require antibiotic treatment. 